Thomas Weisel

Analysts at Thomas Weisel downgrade Walgreen Company (NYSE: WAG) from "overweight" to "market weight." WAG’s shares soared 0.44% to close at $29.96 yesterday. More Analyst Ratings here

Analysts at Thomas Weisel upgrade RightNow (NASDAQ: RNOW) from "market weight" to "overweight." The target price for RNOW is set to $24. RNOW’s shares fell 0.34% to close at $14.55 on Friday. More Analyst Ratings here

Shares of Deckers Outdoor Corp. (NASDAQ: DECK) are higher on the session by 4.32%, currently trading $144.95. The stock has been a relative outperformer as of late and has managed to hold the 50-day moving average as well, which is a bullish sign. Deckers announced a three-for-one stock split this...

Analysts at Thomas Weisel downgrade DreamWorks Animation SKG Inc (NASDAQ: DWA) from "overweight" to "market weight." The target price for DWA has been reduced from $44 to $38. DWA’s shares fell 1,55% to close at $36.27 yesterday. More Analyst Ratings here

Shares of Fuel System Services Inc. (NASDAQ: FSYS) are moving higher today by 3.71% to $29.38 and are making a run at the 50-day and 200-day moving averages from the downside. While a bullish signal has not been triggered yet, the chart appears to be gaining momentum after basing around the $26...

Analysts at Thomas Weisel initiate coverage of MercadoLibre (NASDAQ: MELI) with an "overweight" rating. Shares of MELI closed at $50.14 yesterday. More Analyst Ratings here.

Analyst Stephen Willey of Thomas Weisel maintains his "market weight" rating on Onyx Pharmaceuticals (NASDAQ: ONXX). The 12-month target price for ONXX is set to $29. According to Thomas Weisel, an exploratory open-label trial (BATTLE) “could generate a positive tailwind for ONXX shares in the near...

Analysts at Thomas Weisel maintain their "overweight" rating on Apple (NASDAQ: AAPL). The target price for AAPL has been raised from $280 to $300. Shares of AAPL closed at $92.00 yesterday. More Analyst Ratings here.

Analysts at Thomas Weisel upgrade CF Industries (NYSE: CF) from “market weight” to “overweight.” Shares of CF rose 0.50% to $90.45 during the pre-market session. More Analyst Ratings here.

Analyst Stephen Willey of Thomas Weisel maintains his "overweight" rating on Anadys Pharmaceuticals Inc (NASDAQ: ANDS). The 12-month target price for ANDS is set to $7. According to Thomas Weisel, “There had been some investor concern around the high placebo response rate observed in the placebo...

Analysts at Thomas Weisel maintain their "overweight" rating on Maxim Integrated Products Inc (NASDAQ: MXIM). The 12-month target price for MXIM is set to $25. Maxim Integrated Products has signed a strategic takeover deal amounting to $315 million for Teridian Semiconductor. Thomas Weisel expects...

Analysts at Thomas Weisel upgrade Crocs (NASDAQ: CROX) from “market weight” to “overweight.” The price target for CROX is set to $12. Shares of CROX climbed 5.40% to $9.37 in premarket trading. More Analyst Ratings here.

Analysts at Thomas Weisel maintain their "overweight" rating on EXFO Inc (NASDAQ: EXFO). The target price for EXFO is set to $8. According to Thomas Weisel, “The company saw strong growth in its lower margin optical and copper access test sales but also price competition and a near-term impact from...

Analysts at Thomas Weisel reiterate their "market weight" rating on Danaher Corporation (NYSE: DHR), while raising their estimates for the company. The target price for DHR has been raised from $75 to $80. DHR and Cooper have announced that they would be combining parts of their tools businesses in...

Analysts at Thomas Weisel maintain their "overweight" rating on Netezza Corporation (NYSE: NZ). The target price for NZ has been raised from $14 to $16. Netezza has indicated that visibility into demand continues to be healthy. Thomas Weisel believes that “healthy overall macro environment and...